What is CVE-2023-0089?

CVE-2023-0089 is a high-severity vulnerability in Proofpoint Enterprise_protection, classified under Eval Injection. CVSS score: 8.8/10. Published 2023-03-08.

How severe is CVE-2023-0089?

High severity. CVSS v3 base score is 8.8 out of 10.

RCE in Proofpoint Enterprise_protection

CVE-2023-0089

The webutils in Proofpoint Enterprise Protection (PPS/POD) contain a vulnerability that allows an authenticated user to execute remote code through 'eval injection'. This affects all versions 8.20.0 and below.

EPSS: 0.007 (49.7th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 8.8 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H.

Affected products

Proofpoint Enterprise_protection — versions 8.20.0, 8.18.6, 8.*

Weakness classification (CWE)

CWE-95 — Eval Injection
CWE-94 — Code Injection

References

security@proofpoint.com (Vendor Advisory)

Frequently asked questions

What is CVE-2023-0089?: CVE-2023-0089 is a high-severity vulnerability in Proofpoint Enterprise_protection, classified under Eval Injection. CVSS score: 8.8/10. Published 2023-03-08.
How severe is CVE-2023-0089?: High severity. CVSS v3 base score is 8.8 out of 10.